Tag: Osteoporosis
Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday
Lower femoral neck bone mineral density and T scores for fracture versus non-fracture group
USPSTF Posts Osteoporosis Screening Recommendations
All women ≥65, high-risk postmenopausal women <65 should undergo bone measurement testing
Bone Strength + Bone Mineral Density Screening Cost-Effective
Model shows this combo starting at age 55 in postmenopausal women prevents fractures
Effect of Osteoporotic Fractures Similar to Diabetes Burden
Findings for quality of life with hip fractures, vertebral compression vs. vision loss, amputation
ASBMR: Romosozumab Reduces Fracture Rate in Osteoporosis
Reduced risk of new vertebral fractures, nonvertebral fractures for romosozumab and alendronate
Prevalence of Vertebral Fracture Varies With Assessment Method
Significantly different prevalence for quantitative morphometry, algorithm based qualitative methods
Review Spotlights Optimal Care of T2DM + Osteoporosis
Preferred T2DM meds are sulfonylureas, DPP-4is, GLP-1 receptor agonists
ACP: Recommendations Updated for Low Bone Density Treatment
Osteoporotic women should be treated with pharmacologic therapy for 5 years to cut fracture risk
Osteoporosis Tx Ups Survival in Postmenopausal Breast Cancer
Improved event-free survival, distant disease-free survival among postmenopausal breast CA patients
Older Women Show Limited Understanding of Osteoporosis
Even after an osteoporosis-related fracture, few women are on pharmacotherapy
